MedTrace Logo

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

NCT01654848 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2012-08-01

No results posted yet for this study

Summary

In a prospective observational study the incidence of Heparin-induced Thrombocytopenia (HIT) Type 2 after orthotopic liver transplantation, associated factors, and hemostaseological findings in thrombocytes and anti-body patterns is going to be investigated.

Conditions

  • Heparin-induced Thrombocytopenia
  • Liver Transplantation

Sponsors & Collaborators

  • University Medicine Greifswald

    collaborator OTHER

  • CHIR-Net

    lead NETWORK

Principal Investigators

  • Volker Assfalg, MD · Klinikum rechts der Isar, Dept. of Surgery

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654848 on ClinicalTrials.gov